2015
DOI: 10.1016/j.ram.2014.12.004
|View full text |Cite
|
Sign up to set email alerts
|

Development of an enhanced bovine viral diarrhea virus subunit vaccine based on E2 glycoprotein fused to a single chain antibody which targets to antigen-presenting cells

Abstract: Bovine viral diarrhea virus (BVDV) is an important cause of economic losses worldwide. E2 is an immunodominant protein and a promising candidate to develop subunit vaccines. To improve its immunogenicity, a truncated E2 (tE2) was fused to a single chain antibody named APCH, which targets to antigen-presenting cells. APCH-tE2 and tE2 proteins were expressed in the baculovirus system and their immunogenicity was firstly compared in guinea pigs. APCH-tE2 vaccine was the best one to evoke a humoral response, and f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
4
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 15 publications
0
4
1
Order By: Relevance
“…In the present study, the prevalence of ETEC genes ( estA and elt ) was lower than 3% in each case, which was lower than previous findings in the region ( 47 ). Within the 303 isolates examined, 6 belonged to EPEC ( eae +) and only 2 to EHEC/STEC ( eae +/ stx1 +).…”
Section: Discussioncontrasting
confidence: 92%
“…In the present study, the prevalence of ETEC genes ( estA and elt ) was lower than 3% in each case, which was lower than previous findings in the region ( 47 ). Within the 303 isolates examined, 6 belonged to EPEC ( eae +) and only 2 to EHEC/STEC ( eae +/ stx1 +).…”
Section: Discussioncontrasting
confidence: 92%
“…Vaccines commercially available for BVDV prevention in Uruguay are manufactured with inactivated virus and can only provide partial protection, unlike modified-live vaccines used in other regions [56], including South American countries such as Brazil [57]. Recent investigations in Argentina have led to developing an enhanced BVDV subunit vaccine expressed in a baculovirus, based on a truncated E2 glycoprotein fused to a single-chain antibody that targets antigenpresenting cells [58]. This vaccine's immunogenicity was tested in guinea pigs and cattle, and immunized cattle developed high levels of neutralizing antibodies against BVDV up to 1 year after immunization.…”
Section: Discussionmentioning
confidence: 99%
“…However, the targeting of molecules expressed concurrently by several antigen presenting cell types has also led to improved antibody responses in different species. This is the case of MHC class II targeting, as demonstrated in pigs 63 , in cows 64 and recently by some of us in pigs and ferrets 65 . Indeed MHC class II-targeting may operate through promoting positive interactions between the targeted subsets, such as DC and B cells which express the molecule 66 .…”
Section: Discussionmentioning
confidence: 72%